A novel anti-MUC1 antibody against the MUC1 cytoplasmic tail domain: Use in sensitive identification of poorly differentiated cells in adenocarcinoma of the stomach

Gastric Cancer

Volumn 15, Issue 4, 2012, Pages 370-381

  Yonezawa, Suguru ^a   Kitajima, Shinichi ^b   Higashi, Michiyo ^a   Osako, Masahiko ^c   Horinouchi, Michiko ^c   Yokoyama, Seiya ^a   Kitamoto, Sho ^a   Yamada, Norishige ^a,d   Tamura, Yukihiro ^a,e   Shimizu, Takeshi ^c   Tabata, Mineo ^c   Goto, Masamichi ^a,f  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY HOSPITAL   (Japan)

^c Kagoshima City Hospital   (Japan)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e Ohsumi Kanoya Hospital   (Japan)

^f National Sanatorium Hoshizuka Keiaien   (Japan)

Author keywords

Accurate detection; Cytoplasmic tail domain; Monoclonal antibody; MUC1; Scirrhous gastric cancer

Indexed keywords

CYTOKERATIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MUC1 014E; MONOCLONAL ANTIBODY MUC1 AB 5; MONOCLONAL ANTIBODY MUC1 DF3; MUCIN 1; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER INVASION; CELL ADHESION; CELL ISOLATION; CONTROLLED STUDY; CYTOPLASMIC TAIL DOMAIN; GASTRECTOMY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; POORLY DIFFERENTIATED STOMACH ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN STRUCTURE; SIGNET RING CARCINOMA; STOMACH ADENOCARCINOMA; TANDEM REPEAT; TUMOR BIOPSY; TUMOR GROWTH;

ADENOCARCINOMA; ADENOCARCINOMA, SCIRRHOUS; AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; CARCINOMA, SIGNET RING CELL; CELL DIFFERENTIATION; CYTOPLASM; GASTRECTOMY; GASTRIC MUCOSA; HUMANS; IMMUNOHISTOCHEMISTRY; MOLECULAR SEQUENCE DATA; MUCIN-1; PROTEIN STRUCTURE, TERTIARY; STOMACH NEOPLASMS;

EID: 84870362899     PISSN: 14363291     EISSN: 14363305     Source Type: Journal    
DOI: 10.1007/s10120-011-0125-2     Document Type: Article

References (24)

1. Nishi M, Omori Y, Miwa K. Japanese classification of gastric carcinoma. 1st English edn. Japanese Research Society for Gastric Cancer. Tokyo: Kanehara; 1995. p. 39-43.
2. Lewin KJ, Appelman HD. Carcinoma of the stomach. In: Rosai J, Sobin LH, editors. Tumors of the esophagus and stomach. Atlas of tumor pathology, 3rd series, fascicle 18. Washington, DC: Armed Forces Institute of Pathology; 1996. p. 245-330.
3. Hollingsworth MA, Swanson BJ. Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer. 2004;4: 45-60.
4. Yonezawa S, Goto M, Yamada N, Higashi M, Nomoto M. Expression profiles of MUC1, MUC2, and MUC4 mucins in human neoplasms and their relationship with biological behavior. Proteomics. 2008;8: 3329-41.
5. Yonezawa S, Higashi M, Yamada N, Yokoyama S, Goto M. Significance of mucin expression in pancreatobiliary neoplasms. J Hepatobiliary Pancreat Sci. 2010;17: 108-24.
6. Moniaux N, Escande F, Porchet N, Aubert JP, Batra SK. Structural organization and classification of the human mucin genes. Front Biosci. 2001;6:D1192-206.
7. Osako M, Yonezawa S, Siddiki B, Huang J, Ho JJ, Kim YS, et al. Immunohistochemical study of mucin carbohydrates and core proteins in human pancreatic tumors. Cancer (Phila). 1993;71: 2191-9.
8. Yamashita K, Yonezawa S, Tanaka S, Shirahama H, Sakoda K, Imai K, et al. Immunohistochemical study of mucin carbohydrates and core proteins in hepatolithiasis and cholangiocarcinoma. Int J Cancer. 1993;55: 82-91.
9. Kufe DW. Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer. 2009;9: 874-85.
10. Wen Y, Caffrey TC, Wheelock MJ, Johnson KR, Hollingsworth MA. Nuclear association of the cytoplasmic tail of MUC1 and beta-catenin. J Biol Chem. 2003;278: 38029-39.
11. Carson DD. The cytoplasmic tail of MUC1: a very busy place. Sci Signal 2008;1:pe35.
12. Mahanta S, Fessler SP, Park J, Bamdad C. A minimal fragment of MUC1 mediates growth of cancer cells. PLoS One. 2008;3:e2054.
13. Schroeder JA, Thompson MC, Gardner MM, Gendler SJ. Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland. J Biol Chem. 2001;276: 13057-64.
14. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215: 403-10.
15. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature (Lond). 1975;256: 495-7.
16. Kufe D, Inghirami G, Abe M, Hayes D, Justi-Wheeler H, Schlom J. Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma. 1984;3: 223-32.
17. Siddiqui J, Abe M, Hayes D, Shani E, Yunis E, Kufe D. Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen. Proc Natl Acad Sci USA. 1988;85: 2320-3.
18. Ren J, Raina D, Chen W, Li G, Huang L, Kufe D. MUC1 oncoprotein functions in activation of fibroblast growth factor receptor signaling. Mol Cancer Res. 2006;4: 873-83.
19. Utsunomiya T, Yonezawa S, Sakamoto H, Kitamura H, Hokita S, Aiko T, et al. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. Clin Cancer Res. 1998;4: 2605-14.
20. Lauwers GY, Garneiro F, Graham DY, Curado M-P, Franceschi S, Montgomery E, et al. Tumours of the stomach. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO classification of tumours of the digestive system. 4th edn. Lyon: International Agency for Research on Cancer; 2010. p. 45-80.
21. Kushima R, Matsubara A, Takemura S, Okabe H, Hattori T. Immunohistochemistry useful for diagnosis: stomach-gastritis and gastric epithelial neoplasms. Pathol Clin Med 2007;25: 42-56 (in Japanese).
22. Arai T, Takubo K. Clinicopathological and molecular characteristics of gastric and colorectal carcinomas in the elderly. Pathol Int. 2007;57: 303-14.
23. Shiao YH, Bovo D, Guido M, Capella C, Cassaro M, Busatto G, et al. Microsatellite instability and/or loss of heterozygosity in young gastric cancer patients in Italy. Int J Cancer. 1999;82: 59-62.
24. Carvalho R, Milne AN, van Rees BP, Caspers E, Cirnes L, Figueiredo C, et al. Early-onset gastric carcinomas display molecular characteristics distinct from gastric carcinomas occurring at a later age. J Pathol. 2004;204: 75-83.